Trial NCT00088881

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02957
Secondary IDs: E3402 U10CA021115

Last trial update was posted on 2017-05-25

MeSH Interventions

Cyclophosphamide Doxorubicin Liposomal doxorubicin Prednisone Rituximab Vincristine

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, B-Cell, Marginal Zone Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin Waldenstrom Macroglobulinemia

Other Conditions

Contiguous Stage II Adult Diffuse Large Cell Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Splenic Marginal Zone Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Testicular Lymphoma Waldenström Macroglobulinemia

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID